About us

In 1927 the pharmacist Julius Wolf founded Nordmark Werke, now based in Uetersen near Hamburg, Germany. Biologicals were the company's business right from the start. Continuous improvement is a distinguishing feature of Nordmark products to this day. Nordmark continuously produces new and improved products based on in-house development know-how, science and technology, keeping pace with ever changing regulatory requirements.

The main active drug substance produced in Uetersen is pancreatin, an extract containing vital digestive enzymes obtained from porc pancreas glands. Nordmark has served the healthcare community with this product for three decades.

Our know-how acquired in 30 years of experience enables us to supply a full range of pancreatin products and services as well as the substance itself. Our product range embraces a selection of product grades, extensive analytical services and documentation. We also manufacture custom-made products and finished pharmaceuticals to individual customers' specifications. With the care and reliability that comes with experience and a sense of responsibility, our products never fail to meet the highest quality standards. Pancreatin from Uetersen stands for top class quality and service. Nordmark left the BASF Pharma alliance in early March 2001. Nordmark is your independent and flexible pharmaceutical partner of choice for biological active pharmaceutical ingredients and medicinal products at all stages in the value-added chain and a full range of relevant services.

Nordmark is your specialist for:

• Development of active biological ingredients
• Manufacture of active biological ingredients, notably pancreatin, collagenase
    and heparin / low molecular weight heparin
• Production of medicinal products containing these active drug substances
• Pharmaceutical development
• Contract manufacture of pharmaceutica
• Manufacture of food supplements

Our technological know-how encompasses

Active pharmaceutical ingredients:
Biotechnological fermentation - microorganism strain storage -
chromatographic purification - protein characterization - organ extraction -

Pharmaceutical development:
Manufacture of all solid dosage forms (specialty formulations: microtablets, effervescent tablets) - liquid dosage forms and ointments - sterile ointments.

Our certified plants for sourcing active drug substances from animal material (such as pancreatic glands) and the biotechnological know-how to produce fermentation-derived drug substances sharpen our competitive edge and benefit our customers.

Compliance with national and international regulatory requirements is verified on a regular basis, for example through on-site audits. Environmentally relevant areas are also EMAS (Eco-Management and Audit Scheme)-certified.